Related Experiment Video
Updated: Mar 26, 2026

07:18
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
7.5K
Poorly differentiated Sertoli-Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
Rachel Brightwell1, Kassondra Grzankowski1, John Kasznica2
1Department of Gynecologic Oncology,Roswell Park Cancer InstituteBuffalo,NY, USA.
Gynecologic Oncology Reports
|January 22, 2016
Abstract:
•Treatment of sex-cord stromal tumors with carboplatin and taxane is both feasible and safe.•FOXL2 mutations account for approximately 50% of these tumors.•Carboplatin and taxane may afford a favorable outcome.

